Positron emission tomography with`50-labeled water (H2150) can be used to delineate abnormal regional myocardial blood flow in experimental animals. To determine the feasibility of this method in humans, we studied 33 subjects (9 normal volunteers and 24 patients with angiographically documented coronary artery disease) at rest and after myocardial hyperemia induced with intravenous infusion of dipyridamole. At rest, the myocardial region demonstrating the lowest relative H2`50 activity exhibited 71 + 8% of activity in the region with peak activity in control subjects and 62 + 17% in patients (p = NS). After the dipyridamole infusion, differences between the two groups were accentuated. In control subjects, activity in the region with lowest relative radioactivity averaged 77 5% of that in the region with peak activity. In patients, it averaged 55 ±+22% of activity in the region with peak activity (p<0.01). Results in patients with ischemia with or without a history of remote myocardial infarction were not significantly different. In 22 of the 24 patients, the region with lowest relative perfusion corresponded anatomically to the region of myocardium distal to a stenosis. Thus, delineation of regional myocardial perfusion in patients with coronary artery disease is possible with positron emission tomography and H215O. Further studies will be necessary to prospectively determine sensitivity and specificity. (Circulation 1988;78:612- Received July 27, 1987; revision accepted May 5, 1988.`3 N-labeled ammonia2-4 and 52Rb5-7 have been successfully used to estimate regional myocardial blood flow in experimental animals and in patients. 82Rb is particularly attractive in the clinical setting because it is generator produced, which obviates the need for an on-site cyclotron. However, the use of these tracers for quantification of flow entails some limitations. Single-pass extraction and myocardial retention of`3N-labeled ammonia are influenced by flow23,8 as well as by cell membrane integrity9 and the metabolic state of the myocardium.8 9 Extraction of 82Rb also varies with flow and metabolism. 5, 6, 10 An ideal perfusion tracer should be either freely diffusible or completely extractable and retainable by myocardium on a single pass through the coronary circulation without having its kinetics altered throughout the range of flow studied or by the metabolic status of the myocardium. 150-labeled water (H2`50) is essentially a freely diffusible tracer in the heart with uptake that does not vary despite wide variations in flow rate11 or changes in the metabolic state of myocardium associated with prolonged ischemia or reperfusion. 11-14 150 is a useful
Positron emission tomography with`50-labeled water (H2150) can be used to delineate abnormal regional myocardial blood flow in experimental animals. To determine the feasibility of this method in humans, we studied 33 subjects (9 normal volunteers and 24 patients with angiographically documented coronary artery disease) at rest and after myocardial hyperemia induced with intravenous infusion of dipyridamole. At rest, the myocardial region demonstrating the lowest relative H2`50 activity exhibited 71 + 8% of activity in the region with peak activity in control subjects and 62 + 17% in patients (p = NS). After the dipyridamole infusion, differences between the two groups were accentuated. In control subjects, activity in the region with lowest relative radioactivity averaged 77 5% of that in the region with peak activity. In patients, it averaged 55 ±+22% of activity in the region with peak activity (p<0.01). Results in patients with ischemia with or without a history of remote myocardial infarction were not significantly different. In 22 of the 24 patients, the region with lowest relative perfusion corresponded anatomically to the region of myocardium distal to a stenosis. Thus, delineation of regional myocardial perfusion in patients with coronary artery disease is possible with positron emission tomography and H215O. Further studies will be necessary to prospectively determine sensitivity and specificity. (Circulation 1988; 78:612-620) N oninvasive delineation of regional myocardial perfusion in patients has been difficult. Conventional scintigraphy is limited by spatial resolution and by incomplete correction for attenuation and spillover of radioactivity from sources overlying or underlying the myocardium. 1 Positron emission tomography (PET) has been developed in part to overcome these limitations. It permits accurate estimation of the distribution of compounds of physiological interest labeled with positron-emitting isotopes within the limits of spatial and temporal resolution of the particular instrument used and in keeping with the path lengths of positrons in tissue.
N-labeled ammonia2-4 and 52Rb5-7 have been successfully used to estimate regional myocardial blood flow in experimental animals and in patients. 82Rb is particularly attractive in the clinical setting because it is generator produced, which obviates the need for an on-site cyclotron. However, the use of these tracers for quantification of flow entails some limitations. Single-pass extraction and myocardial retention of`3N-labeled ammonia are influenced by flow23,8 as well as by cell membrane integrity9 and the metabolic state of the myocardium.8 9 Extraction of 82Rb also varies with flow and metabolism. 5, 6, 10 An ideal perfusion tracer should be either freely diffusible or completely extractable and retainable by myocardium on a single pass through the coronary circulation without having its kinetics altered throughout the range of flow studied or by the metabolic status of the myocardium. 150-labeled water (H2`50) is essentially a freely diffusible tracer in the heart with uptake that does not vary despite wide variations in flow rate11 or changes in the metabolic state of myocardium associated with prolonged ischemia or reperfusion. [11] [12] [13] [14] 150 is a useful tracer for the assessment of myocardial perfusion because its short half-life (2.1 minutes) allows rapid, sequential measurement of perfusion in myocardium of patients during resting conditions or during pharmacologically induced vasodilator stress.
We and others have shown that PET with 'solabeled water can be used to quantify myocardial blood flow throughout wide ranges of flow in experimental animals. [11] [12] [13] [14] We recently demonstrated that blood flow thus detected distal to a subcritical coronary stenosis was normal at rest but that the hyperemic response to dipyridamole was attenuated in regions distal to stenoses of 50-70% diameter.13 The present study was designed to determine whether this approach is possible in patients and to assess its usefulness in delineating impaired nutritive flow in patients with angiographically documented coronary artery disease.
Subjects and Methods Preliminary Studies: Training Set Before beginning the studies described below, we tried vigorously to define the optimal protocols for appropriate positioning of patients, administration of tracer, data acquisition, and data processing. These The experimental protocol was approved by the Human Studies Committee of the Washington University Institutional Review Board, and the nature of the study was explained to each subject before obtaining written, informed consent. Patients and control subjects were studied in a random sequence.
Each subject was positioned in Super PETT 1,16 a whole-body positron tomograph that permits simultaneous acquisition of data sufficient for reconstruction of seven transaxial slices with a center-tocenter slice separation of 1.5 cm and a slice thickness of 1.14 cm. A tomographic transmission scan of the chest was obtained with a 'Ge/IGa ring source to correct for photon attenuation of the emitted radiation. This scan was viewed before the collection of emission data to ensure proper positioning of the patient so that four to six of the seven crosssectional imaging planes were through the heart. Correct positioning was maintained throughout the study with the use of a light beam and indelible marks on the subject's torso. Polyurethane molds were made individually for each subject before each study and were used to stabilize the head, neck, and upper torso of the subject so that movement between data acquisitions was minimized. Emission data were collected in high-resolution mode.
To assess relative myocardial blood flow with 
Hemodynamics
Heart rate, blood pressure, and the electrocardiogram were recorded before and after baseline imaging and at least every 2 minutes after the initiation of the infusion of dipyridamole until tomography was complete. In control subjects, heart rate increased from a baseline of 61 + 7 beats/min to 87 ± 11 beats/min at an average of 8.7 minutes after beginning the infusion of dipyridamole (p<0.001). Mean blood pressure changed from 86 ± 8 mm Hg to 91±10 mm Hg (p-NS). In patients, heart rate increased from 66 ± 12 beats/min (p -NS compared with control subjects) to 84 ± 12 (p = NS compared with control subjects) at an average of 6.4 minutes after onset of infusion of dipyridamole (p<0.001 compared with baseline). Mean blood pressure at baseline was 99±15 mm Hg (p<0.05 compared with control subjects) and did not change significantly after dipyridamole infusion, 101 + 16 mm Hg (p = NS compared with control subjects).
Dipyridamole induced occasional flushing or headache. In five patients, attenuating the effects of dipyridamole was necessary because of prolonged angina. In these patients, aminophylline was administered after imaging.
Tomographic Estimates of Blood Flow
Three tomographic reconstructions that were obtained in a representative study of a normal The midventricular sections show the septum and lateral walls as well. The discontinuity that is posterior in midventricular sections is attributable to the mitral valve apparatus and atria that are below the spatial resolution of positron tomography. The most apical sections show the posterior and inferior walls of the heart. In all reconstructions shown, the septum is on the left, the anterior wall is on the top, and the lateral wall is on the right.
Results in all normal control subjects showed homogeneous H2150 activity in each left ventricular reconstruction, which is indicative of homogeneous perfusion. There were no regional disparities in activity of H2`50 at rest, and dipyridamole stress did not induce regional disparities. After dipyridamole infusion, all myocardial regions in reconstructions from control subjects exhibited at least 70% of peak myocardial H2`50 activity. An example of results from a normal control subject is shown in Figure 2 .
Results in patients with coronary artery disease showed significantly greater heterogeneity of H2150 activity. An example of results from a patient is shown in Figure 3 . Angiography 1 month before study had demonstrated a high-grade occlusion of the proximal left anterior descending artery and no other significant lesions. Tomographic reconstructions for this patient showed homogeneous H2150 activity in the most cephalad section (top of figure) during resting conditions and vasodilator stress. The midventricular sections showed decreased accumulation of H2'"0 in anterior and anteroseptal regions. The regional decreases of activity were marked in the rest study and became even more prominent after vasodilator stress.
To compare results from patients with coronary artery disease with those from normal control subjects, a "defect slice" was identified for each subject, that is, the single tomographic reconstruction that contained the region demonstrating the lowest H2150 activity for the entire individual study. The resting and stress studies were analyzed separately so that a resting slice and a stress defect slice were identified. Normal control subjects would not be expected to exhibit perfusion defects during physiological conditions. Likewise, even a patient with diffuse, severe three-vessel coronary artery disease would be expected to have some regions of myocardium proximal to stenoses that nevertheless were perfused normally. Therefore, a very basal tomographic reconstruction that delineates only a small region of the heart may demonstrate no regional perfusion abnormalities. To avoid simply comparing normally perfused regions from patients with those from normal control subjects, the single tomographic reconstruction that contained the region with the lowest H2150 activity was identified for each subject and used as a reference. In normal control subjects, the diminished regional radioactivity that was identified most likely reflected reduction of count recovery because of partial volume effects.
In control subjects at rest, the region exhibiting the lowest H50 activity yielded counts averaging 71 8% of those in the region with peak activity (Figure 4 ). In patients, the region exhibiting the lowest activity yielded counts averaging 62 ± 17% of those in the region with peak activity (p-NS). In contrast, a distinction between the two groups became apparent when results after dipyridamole stress were considered. In the control subjects, activity in the region with the lowest activity averaged 77 + 5% of that in the region with peak activity. In patients, it averaged only 55 ± 22% of that in the region with peak activity (p<O.Ol).
To further clarify how responses to dipyridamole differed in patients and control subjects, the relative homogeneity of activity in the tomographic reconstruction acquired after infusion of dipyridamole was compared with the relative homogeneity of activity in the reconstruction from the same anatomic level in the study at rest. Because the single region with lowest activity in the resting study of a given individual was not always the single region of lowest activity in the study after dipyridamole (especially in normal subjects in whom homogeneity of activity was the rule), we selected the region of lowest activity from the study after infusion of dipyridamole (i.e., the defect slice) and compared it with the same tomographic level of the ventricle from the resting study. This approach was designed to focus on the response of the myocardial region with minimal coronary flow reserve. As shown in Figure 5 , normal subjects exhibited no difference between the mean percent peak activity in the study after infusion of dipyridamole compared with the resting study (77% both before and after dipyridamole). In contrast, patients exhibited a decrease of the mean percent peak activity in the study after infusion of dipyridamole compared with the rest study [55 + 22% compared with 70 ± 18% (p<0.01)].
In studies involving a freely diffusible tracer, the tracer should measure perfusion alone. The metabolic state of the tissue (including infarction) should have no effect on the measurement. To determine whether the inclusion of patients with remote myocardial infarction introduced a bias in the patient group, data from the eight patients with previous myocardial infarction were analyzed separately as shown in Figure 6 . During resting conditions in the patients with previous infarction, the region exhibiting the lowest relative activity yielded counts averaging 65 ± 19% of those in the region with peak activity. These are values not significantly different from those in patients without previous infarction in whom the region demonstrating the lowest relative normal control subjects and patients. The mean percent peak radioactivity exhibited by the myocardial region with lowest radioactivity after (POST) dipyridamole infusion is compared with that in the same region before (PRE) dipyridamole. In contrast to Figure 4 , the comparison in this figure is of the same regions before and after dipyridamole. Values represent mean±SD (*p<O.OJ).
CAD, coronary artery disease.
activity exhibited counts that averaged 60 + 16% of those in the region with peak activity (p = NS). Likewise, in the studies performed after infusion of dipyridamole, there was no difference in the mean percent peak activity in patients with previous infarction compared with values in patients with no previous infarction (54 + 24% vs. 55 + 22%, p = NS) although these values were distinctly different from those in normal subjects. The coronary lesions, defined angiographically, in the 24 patients were compared with the locations of the region of lowest activity after dipyridamole infusion, defined by PET as shown in Table 1 . Because our analysis delineated relative myocardial perfusion (i.e., one region of myocardium was defined as having maximal activity for comparison with others) only one "defect" region was identified for each subject. Thus, in patients with stenoses in more than one vessel, only the region with the lowest relative perfusion was selected. All but two patients exhibited a tomographic perfusion defect in a locus corresponding to the distribution of tissue supplied by one of the stenosed vessels. In these two patients (patients 5 and 7), the stenosis involved a small, nondominant circumflex vessel, and the region of lowest activity was in the anterior wall. Although there were no discrete stenoses in the left anterior descending artery in either patient, diffuse luminal narrowing was present throughout the left anterior descending coronary artery in both.
This may account for the relative decrease in counts in the anterior wall in these two patients.
Discussion
Nutritive myocardial blood flow distal to coronary stenoses is dependent upon the presence or absence of multiple lesions in a series, the geometry The positron-emitting tracers 13NH3 and 82Rb have been used successfully to characterize alterations of myocardial perfusion in patients with coronary artery disease.4,7 Images obtained with both are of high quality. Because extraction and retention of both tracers are influenced by the metabolic states of myocardium, as well as by perfusion, 1, 3, 5, 6, [8] [9] [10] these tracers can be used to evaluate myocardial meta-bolic activity, as well as flow,6 if enough tracer can be delivered to the myocardial segment in question.
Water labeled with "0 is almost freely diffusible even with hyperemic flow. Its uptake is essentially unaltered by changes in the myocardial metabolic state.'1 Accordingly, its use is compatible with several assumptions inherent in application of a one-compartment mathematical model for quantification of perfusion. 1 11 Because of its short half-life, sequential measurements of perfusion can be made with a low radiation burden. The whole-body dose for combined rest and dipyridamole studies [two H2150 (25) (26) (27) (28) (29) (30) mCi) studies and two C`5O (40) (41) (42) (43) (44) (45) (46) (47) (48) (49) (50) mCi) studies] is 0.25 REMn0 kg.
Nevertheless, several limitations must be considered. Low counting statistics after blood-pool subtraction (a range of 100-400 counts/voxel/min in normal myocardium in studies during resting conditions and after infusion of dipyridamole) result in images that are "noisier" than those with 13NH3 or 82Rb. Results of rest studies, with their intrinsically lower counting statistics, are affected. As noted previously, the region of lowest activity in the study of a subject at rest was not always identical in the same subject after dipyridamole infusion primarily because of the low signal-to-noise ratios in resting images. In patients, no significant difference in the average percent peak activity in the region of lowest activity in the studies during resting conditions compared with after dipyridamole infusion (62 ± 17% vs. 55 ± 22%) was evident. The physiological response to dipyridamole became evident, however, when results in the defect slice in the study after dipyridamole infusion were compared with those results in the same tomographic sections from the resting study. There was a decrease of the mean percent peak activity in patients (70 ± 18% to 55 ± 22%), and there was no change in control subjects. An additional limitation is the need to label the blood pool with C`0 after each H2150 study (i.e., both at rest and after infusion of dipyridamole) to minimize inaccuracies in subtraction that may result from a change in cardiac dimensions.
In this study, we have demonstrated the feasibility of noninvasive characterization of myocardial perfusion with H2150 and PET in human subjects.
Although differences in response to dipyridamole were assessed qualitatively with the method of regional analysis, patients with coronary artery disease were distinguished from control subjects. The presence of a remote myocardial infarction does not appear to bias results. In addition, regions of lowest relative perfusion correlate well with regions of supply distal to angiographically defined coronary stenoses. Further studies involving a larger control group and patients with a wide spectrum of coronary artery disease will be necessary to prospectively determine the sensitivity and specificity of this imaging technique.
Some present instrumentation limitations preclude quantification of flow in absolute terms by PET. As we have shown previously, cardiac and respiratory motion impair absolute quantification of radiation emitted from the myocardium.24 In addition, whenever the dimensions of the object being imaged are less than twice those of the resolution of the instrument, apparent radioactivity in the reconstruction is less than actual radioactivity because of decreased count recovery (partial volume effect). We have observed previously that myocardial radioactivity determined in the anterior region with PET is somewhat low compared with radioactivity assayed by direct counting of tissue samples13" 14, 24 because of the lower recovery of counts from the anterior wall compared with recovery in the lateral, septal, and posterior walls. A transverse section through the chest of a dog provides a slightly oblique section through the posterior left ventricular wall, which results in a thicker cross section than that of the anterior wall and an apparent decrease of radioactivity in the anterior wall because of partial volume effects. Corresponding tomographic anatomy pertains in human subjects as well although midventricular reconstructions are much less affected than more apical reconstructions. Thus 
